|
Question | Discussion | References | CME Credit
Case 3: References
- Bartlett JG, Lane HC, and the Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. October 10, 2006. Available at:
[ AIDSinfo -
Accessed October 16, 2006]
- Perelson AS, Essunger P, Cao Y, et al. Decay
characteristics of HIV-1 infected compartments during combination therapy.
Nature. 1997;387:188-91.
[ PubMed
Abstract]
- Yamashita TE, Phair JP, Munoz A, et al. Immunologic
and virologic response to highly active antiretroviral therapy in the
Multicenter AIDS Cohort Study. AIDS. 2001;15:735-46.
[ PubMed
Abstract]
- Le Moing V, Thiebaut R, Chene G, et al. Predictors
of long-term increase in CD4(+) cell counts in human immunodeficiency
virus-infected patients receiving a protease inhibitor-containing antiretroviral
regimen. J Infect Dis. 2002;185:471-80.
[ PubMed
Abstract]
- Landay AL, Spritzler J, Kessler H, et al.
Immune reconstitution is comparable in antiretroviral-naive subjects
after 1 year of successful therapy with a nucleoside reverse-transcriptase
inhibitor- or protease inhibitor-containing antiretroviral regimen.
J Infect Dis. 2003;188:1444-54.
[ PubMed
Abstract]
- Spritzler J, Mildvan D, Russo A, et al. Can
immune markers predict subsequent discordance between immunologic and
virologic responses to antiretroviral therapy? Adult AIDS Clinical
Trials Group. Clin Infect Dis. 2003;37:551-8.
[ PubMed
Abstract]
- Yeni PG, Hammer SM, Carpenter CC, et al. Antiretroviral
treatment for adult HIV infection in 2002: updated recommendations
of the International AIDS Society-USA Panel. JAMA. 2002; 288: 222-35.
[ PubMed
Abstract]
[Back to Case 3 Question | Back
to Discussion]
CME Credit | Back to Top
|